Stay updated on PDR001/MBG453 w/ Decitabine in AML Clinical Trial
Sign up to get notified when there's something new on the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page.

Latest updates to the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page
- Check2 days agoChange DetectedThe page header's revision label was updated from v3.6.0 to v3.6.2, indicating an update to the underlying platform. This change does not modify the study details or other user-facing information.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now displays recruitment status as no longer recruiting, and new navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) while the Intervention/Treatment heading was added/renamed and the revision label updated to v3.6.0.SummaryDifference0.3%

- Check23 days agoChange DetectedThe site revision label was updated to v3.5.5, replacing the previous v3.5.4, indicating a deployment update on the page. This update does not modify study information or user-facing content.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a minor update to the page's versioning.SummaryDifference0.0%

- Check65 days agoChange DetectedThe page’s footer “Revision” value is updated from v3.5.2 to v3.5.3, indicating a site/version release rather than a change to the clinical trial record itself.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision: v3.5.2.SummaryDifference0.0%

Stay in the know with updates to PDR001/MBG453 w/ Decitabine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page.